Species variability in cardiovascular research: The example of adrenocorticotrophin-induced hypertension

Clinical and Experimental Pharmacology and Physiology

Volumn 33, Issue 9, 2006, Pages 887-891

  Whitworth, Judith A ^a   Zhang, Yi ^a   Mangos, George ^b   Kelly, John J ^b  

^a Australian National University   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

Blood pressure; Dog; Humans; Mouse; Rat; Sheep; Steroids

Indexed keywords

ARGININE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOTROPIN; MINOXIDIL; NISOLDIPINE; NITRIC OXIDE; RAMIPRIL; TETRACOSACTIDE; TETRACOSACTIDE ZINC PHOSPHATE;

BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CONFERENCE PAPER; HUMAN; HYPERTENSION; KIDNEY VASCULAR RESISTANCE; MEDICAL RESEARCH; NONHUMAN; SPECIES; SPECIES DIVERSITY;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CARDIOVASCULAR PHYSIOLOGY; DOGS; GONADAL STEROID HORMONES; HUMANS; HYPERTENSION; MICE; MODELS, ANIMAL; NITRIC OXIDE; RATS; RESEARCH; SHEEP; SPECIES SPECIFICITY;

EID: 33747051730     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2006.04460.x     Document Type: Conference Paper

References (52)

1. Beilin LJ, Bhattacharya J. The effect of indomethacin on autoregulation of renal blood flow in the anasthetized dog. J. Physiol. 1977; 271: 625-39.
2. Goldby FS, Beilin LJ. The evolution and healing of arteriolar damage in renal-clip hypertension in the rat. An electron microscope study. J. Pathol. 1974; 114: 139-48.
3. Beilin LJ, Bhattacharya J. The effect of prostaglandin synthesis inhibitors on renal blood flow distribution in conscious rabbits. J. Physiol. 1977; 269: 395-405.
4. Beilin LJ. The fifth Sir George Pickering memorial lecture. Epitaph to essential hypertension: A preventable disorder of known aetiology? J. Hypertens. 1988; 6: 85-94.
5. Hench PS, Slocumb CH, Polley HF, Kendal EC. Effect of cortisone and pituitary adrenocorticotropic hormone (ACTH) on rheumatic diseases. JAMA 1950; 144: 1372-35.
6. Perera GA. The adrenal cortex and hypertension. Bull. N.Y. Acad. Med. 1950; 26: 75-92.
7. Savage O, Copeman WSC, Chapman L, Wells MV, Treadwell BL. Pituitary and adrenal hormones in rheumatoid arthritis. Lancet 1962; i: 232-5.
8. Treadwell BLJ, Sever ED, Savage O, Copeman WS. Side-effects of long-term treatment with corticosteroids and corticotrophin. Lancet 1964; 13: 1121-3.
9. Whitworth JA, Saines D, Thatcher R et al. Blood pressure and metabolic effects of ACTH in normotensive and hypertensive man. Clin. Exp. Hypertens. A 1983; 5: 501-22.
10. Connell JM, Whitworth JA, Davies DL, Lever AF, Richards AM, Fraser R. Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal man. J. Hypertens. 1987; 5: 425-33.
11. Jackson RV, Nye EJ, Grice JE et al. Early rise in blood pressure following administration of adrenocorticotropic hormone-[1-24] in humans. Clin. Exp. Pharmacol. Physiol. 2001; 28: 773-5.
12. Scoggins BA, Coghlan JP, Denton DA et al. Metabolic effects of ACTH in the sheep. Am. J. Physiol. 1974; 22: 198-205.
13. Cahill F, Coghlan JP, Scoggins BA, Whitworth JA, Wintour EM. Blood pressure and metabolic effects of adrenocorticotrophin after administration to pregnant sheep. J. Endocrinol. 1978; 78: 301-2.
14. Burrell JH, Lumbers ER, Bernasconi C. Effects of ACTH-induced hypertension in the pregnant ewe. J. Cardiovasc. Pharmacol. 1999; 34: 818-23.
15. Scoggins BA, Coghlan JP, Cran EJ et al. Experimental studies on the mechanism of adrenocorticotrophic hormone-induced hypertension in the sheep. Clin. Sci. Mol. Med. Suppl. 1973; 45: S269-71.
16. Haack D, Engel R, Vescei P. The effect of chronic ACTH treatment on blood pressure and urinary excretion of steroids in the rat. Klin. Wochenschr. 1978; 56: 183-6.
17. Freeman RH, Davis JO, Fullerton D. Chronic ACTH administration and the development of hypertension in rats. Proc. Soc. Exp. Biol. Med. 1980; 163: 473-7.
18. Whitworth JA, Hewitson TD, Ming L et al. Adrenocorticotrophin-induced hypertension in the rat: Haemodynamic, metabolic and morphological characteristics. J. Hypertens. 1990; 8: 27-36.
19. Whitworth JA, Hewitson TD, Cornwallis C. Corticotropin effects on blood pressure and fluid and electrolyte homeostasis in five strains of rats. Am. J. Hypertens. 1992; 5: 302-13.
20. Gruber KA, Eskridge-Sloop SL, Eldridge JC, Callahan MF. ACTH-induced hypertension in rats: Fact or artefact? Am. J. Physiol. 1989; 256: R1308-12.
21. Turner SW, Fraser TB, Mangos GJ, Whitworth JA. Circadian blood pressure variability in adrenocorticotrophin-induced hypertension in the rat. J. Hypertens. 2001; 19: 1411-19.
22. Fraser TB, Turner SW, Mangos GJ, Ludbrook J, Whitworth JA. Comparison of telemetric and tail-cuff blood pressure monitoring in adrenocorticotrophic hormone-treated rats. Clin. Exp. Pharmacol. Physiol. 2001; 28: 831-5.
23. Schyvens CG, Mangos GJ, Zhang Y, McKenzie KU, Whitworth JA. Telemetric monitoring of adrenocorticotrophin-induced hypertension in mice. Clin. Exp. Pharmacol. Physiol. 2001; 28: 758-60.
24. Schyvens CG, Cowden WB, Zhang Y, McKenzie KU, Whitworth JA. Hemodynamic effects of the nitric oxide donor DETA/NO in mice. Clin. Exp. Hypertens. 2004; 26: 525-35.
25. Lohmeier TE, Kastner PR. Chronic effects of ACTH and cortisol excess on arterial pressure in normotensive and hypertensive dogs. Hypertension 1982; 4: 652-61.
26. Anderson WP, Ramsey DE. Blood pressure responses to ACTH and adrenaline infusions in dogs. Clin. Exp. Hypertens. A 1985; 7: 525-37.
27. Whitworth JA, Saines D, Scoggins BA. Blood pressure and metabolic effects of cortisol and deoxycorticosterone in man. Clin. Exp. Hypertens. A 1984; 6: 795-809.
28. Whitworth JA, Scoggins BA, Connell JMC. Adrenocortical hypertension. In: Davidson AM (ed). Proceedings of the Xth International Congress of Nephrology. Balliere, London. 1988; 869-83.
29. Spence DC, Coghlan JP, Denton DA, Mills EH, Whitworth JA, Scoggins BA. Adrenocortical steroid requirements for initiation of ACTH-dependent hypertension in sheep. Clin. Exp. Pharmacol. Physiol. 1989; 16: 759-72.
30. Spence CD, Brown A, Coghlan JP, Parkes DG, Whitworth JA, Scoggins BA. Rapid haemodynamic response to adrenocorticotrophin and the role of peripheral resistance in adrenocorticotrophin-induced hypertension in conscious sheep. J. Hypertens. 1989; 7: 277-85.
31. May CN, Bednarik JA. Effects of infusion of combinations of adrenocorticosteroids on systemic and regional haemodynamics in conscious sheep. J. Hypertens. 1996; 14: 475-82.
32. Gamallo A, Alario P, Villanua MA, Nava MP. Effect of chronic stress in the blood pressure in the rat: ACTH administration. Horm. Metab. Res. 1988; 20: 336-8.
33. Mangos GJ, Turner SW, Fraser TB, Whitworth JA. The role of corticosterone in corticotrophin (ACTH)-induced hypertension in the rat. J. Hypertens. 2000; 18: 1849-55.
34. Whitworth JA, Saines D, Andrews J, Sloman JG, Scoggins BA. Haemodynamic response to ACTH administration in essential hypertension. Clin. Exp. Pharmacol. Physiol. 1981; 8: 553-6.
35. Connell JM, Whitworth JA, Davies DL, Richards AM, Fraser R. Haemodynamic, hormonal and renal effects of adrenocorticotrophic hormone in sodium-restricted man. J. Hypertens. 1988; 6: 17-23.
36. Whitworth JA, Kelly JJ, Brown MA, Williamson PM, Lawson JA. Glucocorticoids and hypertension in man. Clin. Exp. Hypertens. 1997; 19: 871-84.
37. Scoggins BA, Allen KJ, Coghlan JP et al. Haemodynamics of ACTH-induced hypertension in sheep. Clin. Sci. 1979; 57 (Suppl.): S333-6.
38. Bednarik JA, May CN. Differential regional hemodynamic effects of corticotropin in conscious sheep. Hypertension 1994; 24: 49-55.
39. May CN, Bednarik JA. Regional hemodynamic and endocrine effects of aldosterone and cortisol in conscious sheep. Comparison with the effects of corticotropin. Hypertension 1995; 26: 294-300.
40. Wen C, Fraser T, Li M, Whitworth JA. Hemodynamic profile of corticotropin-induced hypertension in the rat. J. Hypertens. 1998; 16: 187-94.
41. Wen C, Fraser T, Li M, Turner SW, Whitworth JA. Haemodynamic mechanisms of corticotropin (ACTH)-induced hypertension in the rat. J. Hypertens. 1999; 17: 1715-23.
42. Saruta T. Mechanism of glucocorticoid-induced hypertension. Hypertens. Res. 1996; 19: 1-8.
43. Kelly JJ, Tam SH, Williamson PM, Lawson J, Whitworth JA. Nitric oxide system and cortisol-induced hypertension in humans. Clin. Exp. Pharmacol. Physiol. 1998; 25: 945-6.
44. Kelly JJ, Williamson P, Martin A, Whitworth JA. Effects of oral L-arginine on plasma nitrate and blood pressure in cortisol treated humans. J. Hypertens. 2001; 19: 263-8.
45. Tresham JJ, May CN. Role of nitric oxide in the development of corticotropin-induced hypertension in sheep. Clin. Exp. Pharmacol. Physiol. 1998; 25: 128-30.
46. Wen C, Li M, Fraser T, Wang J, Turner SW, Whitworth JA. L-Arginine partially reverses established adrenocorticotrophin-induced hypertension and nitric oxide deficiency in the rat. Blood Pressure 2000; 9: 298-304.
47. Turner SW, Wen C, Li M, Whitworth JA. L-Arginine prevents corticotropin-induced increases in blood pressure in the rat. Hypertension 1996; 27: 184-9.
48. Wen C, Li M, Whitworth JA. Role of nitric oxide in adrenocorticotrophin- induced hypertension: L-Arginine effects reversed by N-nitro-L-arginine. Clin. Exp. Pharmacol. Physiol. 2000; 27: 887-90.
49. Lou YK, Wen C, Li M et al. Decreased renal expression of nitric oxide synthase isoforms in adrenocorticotrophin-induced and corticosterone-induced hypertension. Hypertension 2001; 37: 1164-70.
50. Martinez LL, Oliveira MA, Miguel AS et al. Losartan attenuates the antimigratory effect of diclofenac in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 2005; 46: 190-9.
51. Wang X, Desai K, Chang T, Wu L. Vascular methylglyoxal metabolism and the development of hypertension. J. Hypertens. 2005; 23: 1565-73.
52. Friese RS, Mahboubi P, Mahapatra NR et al. Common genetic mechanisms of blood pressure elevation in two independent rodent models of human essential hypertension. Am. J. Hypertens. 2005; 18: 633-52.